Bio-Gene Technology Dividends and Buybacks
Dividend criteria checks 0/6
Bio-Gene Technology does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-23.5%
Buyback Yield
Total Shareholder Yield | -23.5% |
Future Dividend Yield | n/a |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
We're Hopeful That Bio-Gene Technology (ASX:BGT) Will Use Its Cash Wisely
Feb 22Here's Why We're Not Too Worried About Bio-Gene Technology's (ASX:BGT) Cash Burn Situation
Oct 25Here's Why We're Not At All Concerned With Bio-Gene Technology's (ASX:BGT) Cash Burn Situation
Jun 20Bio-Gene Technology Limited (ASX:BGT) Is Expected To Breakeven In The Near Future
Apr 28What We Learned About Bio-Gene Technology's (ASX:BGT) CEO Compensation
Jan 11Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if BGT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if BGT's dividend payments have been increasing.
Dividend Yield vs Market
Bio-Gene Technology Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (BGT) | n/a |
Market Bottom 25% (AU) | 2.6% |
Market Top 25% (AU) | 6.0% |
Industry Average (Chemicals) | 2.3% |
Analyst forecast (BGT) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate BGT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate BGT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate BGT's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as BGT has not reported any payouts.